{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:00:04Z","timestamp":1791115204792,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/bor.0b013e3283635634","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T12:28:28Z","timestamp":1375360108000},"page":"630-635","source":"Crossref","is-referenced-by-count":12,"title":["An update on inflammatory myositis in children"],"prefix":"10.1097","volume":"25","author":[{"given":"Adam","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/rheumatology\/keq277","article-title":"Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.","volume":"49","author":"Rider","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1542\/peds.2007-1218","article-title":"Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.","volume":"121","author":"Manlhiot","year":"2008","journal-title":"Pediatrics"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.21068","article-title":"History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.","volume":"53","author":"Pachman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","article-title":"Juvenile dermatomyositis as a paraneoplastic phenomenon: an update.","volume":"32","author":"Morris","year":"2010","journal-title":"J Pediatr HematolOncol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/mus.21669","article-title":"Immunopathogenesis of juvenile dermatomyositis.","volume":"41","author":"Khanna","year":"2010","journal-title":"Muscle Nerve"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3899\/jrheum.111592","article-title":"Antisignal recognition particle-positive juvenile polymyositis successfully treated with rituximab.","volume":"39","author":"Luca","year":"2012","journal-title":"J Rheumatol"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3275","article-title":"Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.","volume":"13","author":"Betteridge","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/rheumatology\/kes073","article-title":"Clinical features of anti-TIF1- antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1- or anti-Mi-2 autoantibodies.","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis.","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM).","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R15-11-20210128","first-page":"S323","article-title":"Progress Report on Development of Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies.","volume":"64","author":"Tjarnlund","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/rheumatology\/keq189","article-title":"Gingival capillary changes and oral motor weakness in juvenile dermatomyositis.","volume":"49","author":"Savioli","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.","volume":"50","author":"Schmeling","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.27379","article-title":"Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.","volume":"62","author":"Ostrowski","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R21-11-20210128","first-page":"117","article-title":"Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis.","volume":"29","author":"Guseinova","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.27218","article-title":"Mortality outcomes in pediatric rheumatology in the US.","volume":"62","author":"Hashkes","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03009742.2011.608376","article-title":"Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.","volume":"41","author":"Mathiesen","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acr.20203","article-title":"Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study.","volume":"62","author":"Sanner","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ard.2010.131433","article-title":"Pulmonary outcome in juvenile dermatomyositis: a case-control study.","volume":"70","author":"Sanner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.21637","article-title":"Quality of life in adults with juvenile-onset dermatomyositis: a case-control study.","volume":"64","author":"Tollisen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"W153","DOI":"10.2214\/AJR.10.5337","article-title":"Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome.","volume":"197","author":"Ladd","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis across North America: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM treatment survey.","volume":"37","author":"Stringer","year":"2010","journal-title":"J Rheumatol"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/acr.20269","article-title":"Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.","volume":"62","author":"Rouster-Stevens","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00296-010-1653-5","article-title":"Mycophenolatemofetil in juvenile dermatomyositis: a case series.","volume":"32","author":"Dagher","year":"2012","journal-title":"Rheumatol Int"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1136\/ard.2011.153718","article-title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis.","volume":"70","author":"Lam","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R33-11-20210128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R34-11-20210128","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","article-title":"Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.","volume":"160","author":"Arabshahi","year":"2012","journal-title":"J Pediatr"},{"key":"R36-11-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/ar3531","article-title":"Type I interferon pathway in adult and juvenile dermatomyositis.","volume":"13","author":"Baechler","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R37-11-20210128","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases.","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-11-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archdermatol.2011.49","article-title":"Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.","volume":"147","author":"Kim","year":"2011","journal-title":"Arch Dermatol"},{"key":"R39-11-20210128","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R40-11-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Childrens Arthritis and Rheumatology Research Alliance Consensus Conference.","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R41-11-20210128","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference.","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R42-11-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1471-2474-11-270","article-title":"Responsiveness to exercise training in juvenile dermatomyositis: a twin case study.","volume":"11","author":"Omori","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"R43-11-20210128","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/acr.21684","article-title":"Exercise training in juvenile dermatomyositis.","volume":"64","author":"Omori","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R44-11-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2474-13-108","article-title":"Design of the muscles in motion study: a randomized controlled trial to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositis.","volume":"13","author":"Habers","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"R45-11-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mus.23484","article-title":"Near-infrared spectroscopy during exercise and recovery in children with juvenile dermatomyositis.","volume":"47","author":"Habers","year":"2013","journal-title":"Muscle Nerve"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3283635634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:42:46Z","timestamp":1715809366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201309000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283635634","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}